Nasal pepsin A

Biomarker of laryngopharyngeal reflux in chronic rhinosinusitis

https://doi.org/10.53730/ijhs.v6nS6.12321

Authors

  • Aditya Wira Buana ORL-HNS Sub Department Faculty of medicine, Hang Tuah University –Dr. Ramelan Naval Hospital, 60244 Surabaya Indonesia
  • Irwan Kristyono ORL-HNS Department Faculty of medicine, Airlangga University – Dr. Soetomo General Hospital, 60286 Surabaya Indonesia
  • Sri Herawati Juniati ORL-HNS Department Faculty of medicine, Airlangga University – Dr. Soetomo General Hospital, 60286 Surabaya Indonesia

Keywords:

laryngopharyngeal reflux, chronic rhinosinusitis, pepsin, pep test

Abstract

Laryngopharyngeal reflux (LPR) can contribute to chronic rhinosinusitis (CRS). Pepsin is believed to be one of the causes of CRS. Pepsin can be a promising biomarker because it is only produced by gastric parietal cells, so it can explain the correlation of CRS with LPR. This study aims to determine the relationship between CRS and LPR based on nasal pepsin examination. The design in this study is a cross-sectional prospective with statistical analysis using the Chi-square method. The research sample were patients with complaints of runny nose and nasal congestion within 12 weeks and met the inclusion and exclusion criteria. All samples were subjected to nasal endoscopy and fiber optic laryngoscope and have Reflux Symptoms Index (RSI) > 13. Specimens from the samples were obtained through the nasal washing method, and pepsin was evaluated using the PepTest lateral flow device. A total of 35 samples in this study consisted of 13 men (37.14%) and 22 women (62.85%). The highest age in the CRS group was the 18-40-year-old group with 16 (64%). A total of 20 (83.3%) CRS patients were positive for pepsin p=0.04 (p<0.05). 

Downloads

Download data is not yet available.

References

Andriani Y, Akil MA, Gaffar M, Punagi AQ. (2011). Deteksi pepsin pada penderitareflukslaringofaring yang didiagnosisberdasarkan reflux symptom index dan reflux finding score. Orli, 41(2), 121–27. https://doi.org/10.32637/orli.v41i2.48

Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, et al. (2014). ICON : Chronic rhinosinusitis, 1–28.https://doi.org/10.1186/1939-4551-7-25

Bardhan, K. D., Strugala, V., &Dettmar, P. W. (2012). Reflux revisited: advancing the role of pepsin. International journal of otolaryngology, 2012, 646901. https://doi.org/10.1155/2012/646901

Belafsky P, Rees C. 2007. Identifying and managing reflukslaringofaringeal. Hospital Physician, (July), 15–21

Benjamin MR, Stevens, WW, Li N, Bose S, Grammer LC, Kern RC, Peters AT. (2019). Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting. Journal of Allergy and Clinical Immunology: In Practice, 7(3), 1010–16. https://doi.org/10.1016/j.jaip.2018.10.014

Beule A. (2015). Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery, p 14. https://doi.org/10.3205/cto000126

Ference, E. H., Tan, B. K., Hulse, K. E., Chandra, R. K., Smith, S. B., Kern, R. C., Conley, D. B., & Smith, S. S. (2015). Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. Allergy & rhinology (Providence, R.I.), 6(2), 82–88. https://doi.org/10.2500/ar.2015.6.0120

Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. (2012). European Position Paper on Rhinosinusitis and Nasal Polyps.Rhinology, (23),p 1–136.https://doi.org/10.4193/Rhin20.600

Gandamayu, I. B. M., Antari, N. W. S., & Strisanti, I. A. S. (2022). The level of community compliance in implementing health protocols to prevent the spread of COVID-19. International Journal of Health & Medical Sciences, 5(2), 177-182. https://doi.org/10.21744/ijhms.v5n2.1897

Hirsch, A. G., Stewart, W. F., Sundaresan, A. S., Young, A. J., Kennedy, T. L., Scott Greene, J., Feng, W., Tan, B. K., Schleimer, R. P., Kern, R. C., Lidder, A., & Schwartz, B. S. (2017). Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy, 72(2), 274–281.https://doi.org/10.1111/all.13042

Katle E, Hatlebakk JG, Omdal R, Kvaløy JT, Steinsvåg SK. (2019). Nasal and salivary pepsin as a biomarker for gastro-esophageal reflux in chronic rhinosinusitis. Rhinology Online, 25–31. Available from: https://www.rhinologyonline.org/Rhinology_online_issues/manuscript_43.pdf Accessed on May 2nd 2019. https://doi.org/10.4193/RHINOL/19.003

Lin YH, Chang TS, Yao YC, Li YC. (2015). Increased risk of chronic sinusitis in adults with gastroesophageal reflux disease. Medicine, 94(39), e1642. https://doi.org/10.1097/MD.0000000000001642

Pérez, A. V., Gámez, M. R., Briones, V. F. . V., Viteri, C. G. V., & Molina, L. A. V. (2018). Sustainable development seen from environmental training in university linkage. International Journal of Life Sciences, 2(1), 12–20. https://doi.org/10.29332/ijls.v2n1.75

Ratunanda SS, Talakua B, Madiadipoera T, Boesoirie T, Anggraeni R, &Ruslami R. (2019). Refluks Helicobacter pylori di mukosahidungpenderitarinosinusitiskronikdisertaireflukslaringofaring. Oto Rhino Laryngologic. Oto Rhino LaryngologicaIndonesiana, 48(2), 148–58.https://doi.org/10.32637/orli.v48i2.272

Ren JJ, Zhao Y, Wang J, Ren X, Xu Y, Tang W, et al. (2017). Pepsin as a marker of reflukslaringofaringeal detected in chronic rhinosinusitis Patients. Otolaryngology - Head and Neck Surgery (United States), 156(5), 893–900. https://doi.org/10.1177/0194599817697055

Samuels, T. L., & Johnston, N. (2010). Pepsin as a marker of extraesophageal reflux. The Annals of otology, rhinology, and laryngology, 119(3), 203–208. https://doi.org/10.1177/000348941011900310

Sella, G., Tamashiro, E., Anselmo-Lima, W. T., & Valera, F. (2017). Relation between chronic rhinosinusitis and gastroesophageal reflux in adults: systematic review. Brazilian journal of otorhinolaryngology, 83(3), 356–363. https://doi.org/10.1016/j.bjorl.2016.05.012

Siupsinskiene, N., Katutiene, I., Jonikiene, V., Janciauskas, D., & Vaitkus, S. (2018). Intranasal Helicobacter pylori infection in patients with chronic rhinosinusitis with polyposis. The Journal of laryngology and otology, 132(9), 816–821. https://doi.org/10.1017/S0022215118001299

Southwood, J. E., Hoekzema, C. R., Samuels, T. L., Wells, C., Poetker, D. M., Johnston, N., &Loehrl, T. A. (2015). The Impact of Pepsin on Human Nasal Epithelial Cells In Vitro: A Potential Mechanism for Extraesophageal Reflux Induced Chronic Rhinosinusitis. The Annals of otology, rhinology, and laryngology, 124(12), 957–964. https://doi.org/10.1177/0003489415593556

Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202

Xu, Y., Quan, H., Faris, P., Garies, S., Liu, M., Bird, C., Kukec, E., Dean, S., &Rudmik, L. (2016). Prevalence and Incidence of Diagnosed Chronic Rhinosinusitis in Alberta, Canada. JAMA otolaryngology-- head & neck surgery, 142(11), 1063–1069. https://doi.org/10.1001/jamaoto.2016.2227

Published

30-08-2022

How to Cite

Buana, A. W., Kristyono, I., & Juniati, S. H. (2022). Nasal pepsin A: Biomarker of laryngopharyngeal reflux in chronic rhinosinusitis. International Journal of Health Sciences, 6(S6), 8599–8608. https://doi.org/10.53730/ijhs.v6nS6.12321

Issue

Section

Peer Review Articles

Most read articles by the same author(s)